The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer
1990

CT Scans for Brain Metastases in Small Cell Lung Cancer

Sample size: 127 publication Evidence: low

Author Information

Author(s): J. Hardy, I. Smith, G. Cherryman, M. Vincent, I. Judson, T. Perren, M. Williams

Primary Institution: Royal Marsden Hospital

Hypothesis

Can regular CT scan surveillance effectively detect brain metastases in patients with small cell lung cancer as an alternative to prophylactic cranial irradiation?

Conclusion

Regular CT scan surveillance is not an effective substitute for prophylactic cranial irradiation in managing brain metastases in small cell lung cancer.

Supporting Evidence

  • 44% of patients developed CNS metastases, with 13% at diagnosis and 31% after chemotherapy.
  • 56% of asymptomatic patients and 60% of symptomatic patients died with active CNS disease despite treatment.
  • Regular CT scanning failed to detect pre-symptomatic disease in one-third of patients who developed CNS metastases.

Takeaway

Doctors used CT scans every three months to check for brain problems in lung cancer patients, but it didn't help them live longer or avoid serious issues.

Methodology

Patients underwent CT scans every three months for two years to detect brain metastases, with treatment provided as necessary.

Limitations

The study did not prevent the morbidity associated with CNS disease and failed to detect pre-symptomatic disease in some patients.

Participant Demographics

Patients with histologically documented small cell lung cancer referred to the Royal Marsden Hospital.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication